Purchase Order HHSN261201500379P

This is a federal contract award from the National Cancer Institute, a civilian agency, to Istituto Oncologico Veneto in Italy. The $99,150.00 Firm Fixed Price contract is for the review of tumor, adjacent normal, and nevus remnant samples, as well as DNA extraction from melanoma and other skin lesions collected from Mediterranean populations. The contract does not have a set-aside designation. No subcontractors are mentioned. The contract supports the National Cancer Institute's research and...

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $12,000 firm fixed price purchase order to UK Biobank Limited. The purpose of this contract is to provide Dr. Stewart and his team access to biobank data including whole exome and genome data on 500,000 individuals linked to electronic health records within UK Biobank. This will support analysis of the frequency, phenotypic spectrum, and penetrance...

The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB) awarded a $397,800.00 firm fixed-price purchase order contract to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation based in Germany. The contract, which does not have a set-aside designation, is for the testing of various elements related to...

This $507,000 firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a German non-profit organization focused on cancer research. The contract requires DKFZ to test no more than 13,000 samples previously collected in the Anchor Trial using a multiplex serology assay of up to 41 antigens. The work is to be performed at DKFZ's facilities in Heidelberg, Germany, with...

This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $180,843 firm-fixed price purchase order contract to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation, to provide services to pull, aliquot (including blinded replicates), package, and ship serum samples for HPV serologic testing and Helicobacter pylori (H. pylori) multiplex serology testing. The contract supports two studies: evaluating...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $102,053.00 firm fixed-price purchase order to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc., a nonprofit hospital and National Cancer Institute-designated comprehensive cancer center, for the procurement of DNA samples to support a multi-ancestry genome-wide association study of lymphoid malignancies. The contract does not utilize any small business set-asides and...

The Centers for Disease Control and Prevention awarded an $8.0 million time and materials contract to Mcking Consulting Corporation on September 23, 2020, to operate and maintain a national biorepository for the National ALS Registry. Under this total small business set-aside contract, Mcking will manage specimen collection, transport, maintenance, cataloging, and logistics for biological samples from over 15,000 amyotrophic lateral sclerosis patients. The biorepository maintains diverse...

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Universitaetsklinikum Essen Anstalt DES Oeffentlichen Rechts, a hospital and non-profit organization in Germany. The contract, valued at $84,525.00, is part of the NCI Cancer Genome Atlas Program and supports the collection of tissue samples and data from various types of cancer. The contract is not designated as a set-aside. Universitaetsklinikum Essen has previously received federal grant subawards from...

This is a firm-fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic. The contract is part of the larger NCI Cancer Genome Atlas Program Tissue Purchase IDIQ contract, with a ceiling value of $6,663.53. Under this order, Mayo Clinic is providing tissue samples and data from various types of cancer to support the NCI's Cancer Genome Atlas (TCGA) program, which is funded under the American Recovery...